Abstract Uterine fibroid (UFs) affect 77 % of women by menopause and account for $9.4 billion in healthcare costs each year. Although UFs are heritable, genetic risk is poorly understood. The first genome-wide association study (GWAS) of UFs was recently performed in a Japanese population, with reported genome-wide significance for single nucleotide polymorphisms (SNPs) across three chromosomal regions. We tested these SNPs for association with UFs in US cohorts. Women were enrolled in the Right from the Start (RFTS) cohort and the BioVU DNA repository. UF status in both cohorts was determined by pelvic imaging. We tested 65 candidate and haplotypetagging SNPs for association with UFs presence using logistic regression in RFTS and the top three GWASassociated SNPs in BioVU. We also combined association results from both cohorts using meta-analysis. 1,086 European American (EA) cases and 1,549 controls were examined. Two SNP associations replicated [blocked early in transport 1 homolog (BET1L) rs2280543, RFTS-BioVU meta-odds ratio (OR) = 0.67 95 % confidence interval (CI) 0.38-0.96, Q = 0.70, I = 0, p = 6.9 9 10 -3 ; trinucleotide repeat containing 6B (TNRC6B) rs12484776, RFTS-BioVU meta-OR = 1.21, 95 % CI 1.07-1.35, Q = 0.24, I = 28.37, p = 8.7 9 10 -3 ). Meta-analyses combining evidence from RFTS, BioVU, and prior GWAS showed little heterogeneity in effect sizes across studies, with meta-p values between 7.45 9 10 -8 and 3.89 9 10 -9 , which were stronger than prior GWAS and supported associations observed for all previously identified loci. These data suggest common variants increase risk for UF in both EA and Japanese populations. However, further research is needed to assess the role of these genes across other racial groups.
Introduction
Uterine leiomyomata, or fibroids (UFs), are the most common female pelvic tumor. Prevalence estimates range from 20 to 77 %, increasing with age up to menopause (Cramer and Patel 1990; Marshall et al. 1997; Vollenhoven 1998) . Known risk factors for UFs include AfricanAmerican (AA) race Cramer and Patel 1990; Faerstein et al. 2001; Marshall et al. 1997; Ojeda 1979) , early age-at-menarche (Dragomir et al. 2010; Faerstein et al. 2001; Lumbiganon et al. 1996; Marshall et al. 1998; Samadi et al. 1996; Wise et al. 2004) , high body mass index (BMI) (Moore et al. 2008; Takeda et al. 2008) , and increased age . In addition, a protective effect for UFs has also been observed with higher parity, likely due to pregnancy-related hormonal and physical changes including postpartum uterine involution Laughlin et al. 2010a Laughlin et al. , 2011 .
Multiple lines of evidence have shown that UFs are influenced by genetic risk factors. First, UFs are highly heritable with evidence from twin-pair and familial aggregation studies (Luoto et al. 2000; Treloar et al. 1992) . Heritability studies of UFs in several European populations have observed that between 26 and 69 % of UF risk is due to genetic factors (Kurbanova et al. 1989; Luoto et al. 2000; Snieder et al. 1998 ). Further supporting a genetic contribution to risk are the observed racial disparities in UF age of onset, number, size, and lifetime incidence by menopause . Genetic epidemiology studies to date have been largely limited to small-scale or single marker studies of steroid hormones, particularly estrogen, as it is potentially the most critical regulator of fibroid growth (Flake et al. 2003) . Also other growth factors (Sozen and Arici 2002) , reproductive factors (Parazzini et al. 1996) , dysregulation of microRNAs (Marsh et al. 2008) , shortening of telomeres (Bonatz et al. 1998) , excessive production of disorganized extracellular matrix (Malik et al. 2010; Sozen and Arici 2002) , and acquired chromosomal aberrations have been noted in UF studies (El-Gharib and Elsobky 2010) .
Recently, a genome-wide association study (GWAS) by Cha et al. (2011) appeared in Nature Genetics that examined risk for UFs among a population of Japanese women. Eleven single nucleotide polymorphisms (SNPs) in three chromosomal regions (10q24.33, 11p15.5, and 22q13.1) were associated with increased risk of UFs. The SNPs identified in the GWAS mapped to or nearby the genes STE20-like kinase (SLK), oligonucleotide/oligosaccharidebinding fold containing 1 (OBFC1), trinucleotide repeat containing 6B (TNRC6B), outer dense fiber of sperm tails 3 (ODF3), blocked early in transport 1 homolog (BET1L), resistance to inhibitors of cholinesterase 8 homolog A (RIC8A), and sirtuin 3 (SIRT3). The degree to which these findings generalize across racial groups is unknown. Based on findings from other complex diseases, the same genetic factors may not explain UF risk across racial groups. Furthermore, since this is a clinical cohort it may be that these SNPs are more associated with severe and/or symptomatic fibroids. To date, there are no published GWAS of UFs in US populations using all imaged subjects.
In efforts to examine the three chromosome regions more comprehensively for an association with UF risk, we examined haplotype-tagging and index SNPs in a European American (EA) US population rather than limiting our selection to only the previously studied variants. To conduct this analysis we used two cohorts of women, all of whom had pelvic imaging performed to detect the presence of UFs. Imaging is critical, because many women with UFs are asymptomatic and without imaging, studies may misclassify as many as 51 % of women Myers et al. 2012) . The primary goal of this study was to determine if gene variants within the previously associated gene regions associate with UF risk in an independent US population.
Materials and methods

Study populations
Right from the Start (RFTS)
RFTS is a community-based pregnancy cohort that enrolled study participants between 2001 and 2012. RFTS enrolled participants from Galveston, Texas; Memphis, Nashville, Knoxville, and Chattanooga, Tennessee; and the Research Triangle region (Raleigh, Durham, and Chapel Hill) in North Carolina. These analyses included RFTS participants who were 18 years or older and non-Hispanic EAs. As a part of participation, consent was obtained to review study participant medical records. Direct marketing and recruitment strategies have been previously described (Promislow et al. 2004 ). The institutional review board (IRB) of Vanderbilt University, Nashville, Tennessee, approved this study.
At enrollment, a research transvaginal ultrasound was conducted to assess embryonic development for the study pregnancy and to systematically examine the uterus for presence of UFs. The fibroid measurement protocol required three separate sets of measurements for each UF, with assessment of three perpendicular diameters: length, width, and depth. RFTS includes fibroids as small as 0.5 cm in maximum diameter (Laughlin et al. 2009 ). Multiple still images of each UF with caliper markings of each diameter were recorded and a UF map was completed indicating the location and type of all UF(s).
Participants completed an intake interview at enrollment and a computer-assisted telephone interview at the end of the first trimester. The intake and first trimester interviews provided information on reproductive history and candidate confounders. DNA samples were obtained either in person or by mail during follow-up using Oragene saliva DNA kits (DNA Genotek Inc., Ontario, Canada).
The BioVU DNA Repository
The BioVU Repository (2007-present) is located at Vanderbilt University, Nashville, TN, and was designed to link clinical data available from de-identified electronic medical records to DNA specimens (Pulley et al. 2010) . The BioVU Repository consists of de-identified blood samples obtained from patients at Vanderbilt University Medical Center Hospital, including all clinics that are part of the hospital system. De-identified data from multiple sources are available within BioVU, including diagnostic and procedure codes, basic demographics, discharge summaries, nursing notes, progress notes, health history, multidisciplinary assessments, laboratory values, echocardiogram diagnoses, imaging reports, electronically derived data, and inpatient medication orders. All subjects (both UF cases and controls) selected from BioVU had diagnostic imaging with ultrasound, magnetic resonance imaging (MRI), or computed tomography (CT). Included as UF cases were women who had diagnostic imaging and either a diagnosis of a UF, as indicated by physician diagnosis of UFs or a surgical procedure for UF removal. For controls, two or more instances of pelvic imaging on separate dates were required. Initial chart review of a small subset of controls suggests that a large proportion of imaging information comes from prior pregnancy ultrasounds. Women with hysterectomy, myomectomy, or other procedures for UFs were excluded as controls. Controls were density matched to UF cases based on date of diagnostic imaging, where controls second imaging date had to be within a 3-to 5-year window of those cases. Both cases and controls were 18-65 years of age. We did not limit controls for age, but did perform secondary analyses limiting controls to those [50 years of age to reduce the possibility that some women might develop a UF after imaging was performed. Our sampling algorithm to define UF cases and controls is informed by a published UF algorithm by Hartmann et al. (2006) using electronic medical records. The IRB of Vanderbilt University, Nashville, TN, approved this study.
SNP selection
SNPs were selected based on either previously being associated with UFs in the GWAS by Cha et al. (2011) or being a haplotype-tagging SNP. The SNPs with the strongest associations by Cha et al. (2011) were rs2280543 (chromosome 11, in the BET1L gene), rs12484776 (chromosome 22, in the TNRC6B gene), and rs7913069 (chromosome 10, not located within a gene, but referred to as ''nearby SLK''). The remaining SNPs selected were haplotype-tagging SNPs within or near these loci. Haplotypetagging SNPs were identified using the HapMap phase III samples (Release 28, http://www.hapmap.org): AfricanAmerican (from the ASW USA), Yoruban from Ibadan, Nigeria (YRI), and Northern and Western European (Centre d'Etude du Polymorphisme Humain (CEPH) family samples from Utah, USA), with the Tagster htSNP linkage disequilibrium (LD) selection tool available from the SNPinfo Web Server (National Institute for Environmental Health Sciences; http://snpinfo.niehs.nih.gov/). Within each reference population SNPs had a minor allele frequency (MAF) of 0.10 or greater were in bins of highly correlated SNPs (r 2 C 0.80), and were located within 5 kb from the boundaries of candidate genes and/or SNPs if the index SNP was not located within a gene. The GWAS index SNPs were forced into the Tagster htSNP selection algorithm and through an iterative approach, a minimum set of htSNPs for study subjects with admixed ancestry were identified (Thorisson et al. 2005; Xu et al. 2007) . A total of 72 SNPs met the above criteria. A summary of the SNPs used in our final analyses is provided in Table 1 and gene schematics are provided on Supplemental Figures 1 through 3. Information regarding SNP location within a gene, its type, and any corresponding amino acid changes (none were found) were sought from the HapMap and the SNPper program (http://snpper.chip.org/).
DNA extraction and genotyping
Genotyping BioVU
BioVU DNA samples were isolated from whole blood using the Autopure LS system (QIAGEN Inc., Valencia, CA). In BioVU we only genotyped the top three associated SNPs from the previously published GWAS (rs7913069, rs2280543, and rs12484776) and they were all genotyped using a TaqMan allelic discrimination assay.
RFTS genotyping
DNA for RFTS saliva samples was extracted using Oragene DNA (Genotek Inc., Ontario, Canada) manufacturer recommended DNA extraction procedures. In the RFTS population, one tag SNP (rs6519215) was genotyped using a TaqMan allelic discrimination assay purchased from the ABI Assay on Demand or Assays by Design services (Life Technologies, Grand Island, NY). The remaining 71 SNPs were genotyped using the Sequenom MassARRAY genotyping platform (Sequenom Inc., San Diego, CA). One SNP (rs5757906) assay failed. The final analytic dataset for RFTS contained 65 SNPs. All SNPs in BioVU and RFTS had genotyping call rates of 95 % or better (mean call rates of 98 %) and QC sample match rates of 100 %. Six SNPs were dropped because of low MAF (\0.01) in the genotyped dataset.
Statistical analysis
Tests for deviations from Hardy-Weinberg equilibrium (HWE) were performed using PLINK statistical software (Purcell et al. 2007) . Statistical significance for these analyses was determined using p values from Fisher's exact tests. Pairwise LD was characterized using the standard summary statistic r 2 from HaploView (Barrett et al. 2005 ) statistical software, where r 2 is the correlation of SNPs in a population that takes into account differences in allele frequencies and is less sensitive to inflation due to small sample size. Haplotype blocks were assigned, using the D 0 confidence interval algorithm created by Gabriel et al. (2002) . Descriptive statistics of demographic data were expressed as frequencies and proportions and compared between women with and without UFs (reference) using unadjusted logistic regression using STATA 11.0 statistical software (College Station, TX). Single locus tests of association with UF risk were performed using logistic regression assuming an additive genotypic model [0 (homozygous major allele) versus 1 (heterozygous) versus 2 (homozygous minor allele)]. Odds ratios (ORs) and confidence intervals (CI) were reported for SNPs from all statistical models. We reported results from both regression models unadjusted and adjusted for potential confounders: age (categorical) and BMI (categorical). Unadjusted models are presented in the manuscript for comparison with the previous results from Cha et al. (2011) ; adjusted models can be found in Supplemental Table 1 . PLINK statistical software was used to perform single locus tests of association (Purcell et al. 2007) .
Single locus association analyses in RFTS and BioVU were further analyzed together with fixed-effects metaanalyses using PLINK, as well as METAL (Purcell et al. 2007; Willer et al. 2010) . We only considered the fixedeffects results among EAs from RFTS and BioVU. Thereby, we sought out only those loci with consistent evidence between the two populations using this approach.
Results
Right from the Start (RFTS)
Fourteen percent of women from RFTS had UFs (n = 89). Age C30 years was associated with increased risk for UFs (Table 2A) . None of the SNPs 65 haplotype-tagging SNPs examined significantly deviated from HWE. In unadjusted analyses, five SNPs associated (p B 0.05) with increased risk of UFs (Table 3) . Among these associated SNPs, one was in the 10q24.33 chromosomal region (rs11191875, OR = 2.78, 95 % CI 1.24-6.26, p = 0.014), one was in BET1L (rs939917, OR = 1.86, 95 % CI 1.12-3.07, p = 0.016;) and three were in TNRC6B (rs11089974, OR = 1.46, 95 % CI 1.01-2.10, p = 0.046; rs12484776, OR = 1.48, 95 % CI 1.03-2.13, p = 0.035; rs4821942, OR = 1.52, 95 % CI 1.06-2.18, p = 0.024). The set of SNPs that were associated with UFs also showed evidence for association after adjustment for age and BMI (Supplemental Table 1 ).
Further examination of the LD structure among the SNPs in TNRC6B that associated with UF risk showed evidence for high LD between rs11089974, rs12484776, and rs4821942-with r 2 values between these SNPs ranging from 0.88 to 0.97 in cases and 0.87 to 0.93 in controls (Supplemental Figure 4) . Based on the strong LD observed between these TNRC6B SNPs, we performed single SNP association analyses conditioning on rs12484776 (GWAS index SNP). These analyses showed that none of the SNPs in TNRC6B were statistically significant after adjusting for rs12484776 in regression models (results not shown). This would suggest that associations at other SNPs in TNRC6B were due to being in LD with rs12484776.
BioVU
BioVU participants were on average older than RFTS study participants (Table 2) . BioVU genotyping data were only for the top three previously associated GWAS SNPs. Fifty percent of women included in these analyses from BioVU had UFs. Similar to women from RFTS, older age was associated with increased risk for UFs (Table 2B ). Greater proportions of women from BioVU had higher BMIs or were older than women in RFTS; this reflects RFTS samples coming from a younger cohort while BioVU represents a clinical population.
None of the SNPs examined significantly deviated from HWE. Among the three index SNPs examined for association with UF risk, two showed evidence for association in unadjusted analyses (BET1L rs2280543 OR = 0.68, 95 % CI 0.51-0.92, p = 0.013; TNRC6B rs12484776 OR = 1.17, 95 % CI 1.00-1.36, p = 0.050) ( Table 3) . This evidence for association with UFs remained after adjusting for age and BMI (Supplemental Table 1) .
We were not able to determine the age at which a study participant developed UFs or if they develop a UF after being screened. To address this in BioVU, we performed secondary analyses limiting BioVU controls to women over 50 (data not shown). Risk estimates for UF were larger when limiting BioVU controls to women over 50 (BET1L rs2280543 OR = 0.71, 95 % CI 0.51-0.99, p = 0.042; TNRC6B rs12484776 OR = 1.26, 95 % CI 1.05-1.51, p = 0.011) suggesting that despite observing consistent associations at index SNPs, the younger subset of controls may have been contributing to phenotypic heterogeneity.
RFTS-BioVU meta-analyses
Meta-analyses across RFTS and BioVU samples showed strong evidence of association at BET1L rs2280543 (meta-OR = 0.67, SE = 0.15, Q = 0.70, I = 0, p = 6.90 9 10 -3 ) and TNRC6B rs12484776 (meta-OR = 1.21, SE = 0.07, Q = 0.24, I = 28.37, p = 8.70 9 10 -3 ) (Table 4) . Finally, in order to assess the consistency of effect sizes and association results with the prior GWAS of a Japanese population, we did a meta-analysis including all RFTS participants, BioVU participants, and the prior Japanese GWAS (Table 4) . Statistical significance was stronger for all three SNPs compared to the level of significance in the prior GWAS. Little evidence of heterogeneity across the study populations was indicated for these SNPs, with Qs ranging from 0.21 to 0.92 and I = 0 to 36.01. The SNP Hum Genet (2013) 132:943-953 947 with the strongest meta-association p value across all populations in RFTS, BioVU, and the prior GWAS of Japanese subjects was BET1L rs2280543 (OR = 0.66, SE = 0.07, Q = 0.92, I = 0, p = 3.89 9 10 -9 ), which associated with p = 7.16 9 10 -7 in the paper by Cha et al. (2011) . This level of statistical significance exceeds the canonical genome-wide threshold for multiple testing, using a Bonferroni correction for multiple testing. It is of note, however, that in the prior GWAS they used the major allele as the risk allele for rs2280543. We used the minor allele as the risk allele in our analyses and our results are consistent for rs2280543 when modeled with the same risk allele.
Discussion
This study is the first replication of the associations previously observed in BET1L and TNRC6B in two EA US cohorts and is enhanced by pelvic imaging for cases and controls. We observed strong evidence of association across several markers in BET1L and TNRC6B including two of the previously associated GWAS index SNPs. The direction of the effect sizes across SNPs in the prior Japanese GWAS and our study were consistent with little evidence of heterogeneity in effect sizes across studies. The very low heterogeneity of effects at these loci between European and Asian populations further support a n, number; OR, odds ratio; CI, confidence interval consistent effect on risk and suggest that this locus may be functional or in tight LD with the functional SNP. We did not replicate the association previously observed at rs7913069 within RFTS or BioVU; however, the SNP was significant when we meta-analyzed including the prior GWAS with a higher level of statistical significance than was previously reported (GWAS p = 7.9 9 10 -8 ). We note, however, we were less powered to detect an association among EAs at this SNP because the MAF was 0.01, while among the Japanese population the MAF was between 0.07 and 0.11 (Cha et al. 2011) .
We note that the associations at the SNPs identified by Cha et al. (2011) did not previously replicate in a cohort of African-American women from the Black Women's Health Study (BWHS) and were not among the top associations reported in a recent association study using women of European ancestry (US European Americans and Australians) (Eggert et al. 2012; Wise et al. 2012) . Inconsistencies in association results between our study and these previously published studies may be due to the genetic ancestry of the study participants, as all of our participants were EAs from the US while the prior two studies consisted of African-Americans and combined subjects of European ancestry from the US and Australia. It may be that these SNPs associate among EAs from the US and Japanese populations but not other racial or geographic groups. Furthermore, the phenotype definition used to define cases and controls by these prior studies was based on self-report, while our studies required imaging confirmation of fibroid status.
The strongest evidence for association with UF came from BET1L and TNRC6B. Neither BET1L nor TNRC6B Bold results indicate p B 0.05 OR, odds ratio; SE, standard error; Q = p value for the Cochrane's Q statistic, I = I 2 heterogeneity index (0-100) a Index SNP from previous GWAS Hum Genet (2013) 132:943-953 949 were previously associated with UF risk, except for the GWAS by Cha et al. (2011) . According to the NHGRI Catalog of Published GWAS (http://www.genome.gov/ gwastudies/), the BET1L SNP rs2280543 has also been associated with intracranial aneurysm in another GWAS in a Japanese population (Low et al. 2012) . Although rs12484776 has not been identified by other GWAS, other SNPs within the TNRC6B have been associated with both prostate cancer risk among EA and height (Estrada et al. 2009; Liu et al. 2011; Sun et al. 2009; Tao et al. 2012) . TNRC6B has been shown to interact with insulin-like growth factors 2 (IGF-2) to increase risk for prostate cancer (Tao et al. 2012) . Furthermore, quantitative trait loci within the region of TNRC6B have been shown to be associated with age-at-menarche and early age-at-menarche is an established risk factor for UF (Dragomir et al. 2010; Faerstein et al. 2001; Guo et al. 2006; Lumbiganon et al. 1996; Marshall et al. 1998; Samadi et al. 1996; Wise et al. 2004) . BET1L is involved in endoplasmic reticulum to golgi transport, while TNRC6B is involved in RNA interference machinery and is important for miRNA RNAdependent translational regression or degradation of target RNAs. TNRC6B is a potential biological target as miRNAs have been previously implicated in leiomyoma pathogenesis (Luo and Chegini 2008; Meister et al. 2005 ).
Further examination of the genes near the GWAS index SNPs show strong evidence of those genes being involved in cardiovascular-related health conditions. OBFC1 has been associated with cardiovascular disease and SIRT3 with metabolic syndrome, mitochondrial function, obesity, and exercise response in prior studies (Borengasser et al. 2011; Burnett-Hartman et al. 2012; Capel et al. 2008; Choudhury et al. 2011; Giralt and Villarroya 2012; Green and Hirschey 2012; Guarente 2011; Mestre-Alfaro et al. 2012; Valdecantos et al. 2012; Vasan et al. 2007 ). Insertion/deletions within the BET1L chromosomal region have also been implicated in glucose regulation and type II diabetes (Owerbach et al. 1982; Rotwein et al. 1981) . These data suggest that genes associated with metabolic complications and cancer may also be involved with UF pathogenesis, which is interesting as being overweight is a risk factor for UFs (Baird et al. 2007; Takeda et al. 2008; Terry et al. 2007; Wise et al. 2005) . Further research is necessary to assess the possible role of genetic interactions with cardiovascular outcomes in UF risk.
There are no other established genetic risk factors for UFs. In addition to the recently published GWAS by Cha et al. (2011) there have been three other prominently published large-scale genetic association studies (Eggert et al. 2012; Makinen et al. 2011; Wise et al. 2012 ). These include a tumor sequencing study published by Makinen et al. (2011) published in the journal Science, a GWAS of UF using a EA family and population-based sample (Eggert et al. 2012) , and an admixture mapping analysis using African-American populations (Wise et al. 2012) . Among these only the study by Makinen et al. (2011) has been validated in multiple independent studies. The Eggert study observed one locus at genome-wide significance, but without an independent replication. Makinen et al. (2011) examined somatic mutations in tumor tissue and found most UFs had mutations at the gene mediator complex subunit 12 (MED12), a result that has replicated across independent multi-ethnic populations Makinen et al. 2011) . MED12 is a 26-subunit transcriptional regulator that bridges DNA regulatory sequences to the RNA polymerase II initiation complex. All associated mutations resided in exon 2, suggesting that aberrant function of this region of MED12 contributes to tumorigenesis. Although some recent research suggests that mutations in MED12 are specific to UF tissue , other studies suggest that MED12 may be involved in multiple pathways that contribute to tumor growth in other tissues (Markowski et al. 2012) . Further supporting the later hypothesis is a recent study published in Nature Genetics showing that MED12 mutations are also present in prostate cancer tumor tissue (Barbieri et al. 2012) . Further research can elucidate any relationship MED12 may have with the genes identified by Cha et al. (2011) .
A significant strength of our study is that all women were systematically screened for UFs using a standardized protocol and endovaginal ultrasounds for RFTS and various forms of pelvic imaging for BioVU. The majority of other UF studies did not have imaging data available for all subjects, but instead relied on clinical diagnosis of UFs. As a result, misclassification of UFs within our cohorts should be very low. Additionally, although BioVU participants had a higher mean age than RFTS participants who were primarily in their 20s. It may be that women with UFs in the RFTS cohort represent a group with an early onset of the condition, because estimates of age-specific cumulative incidence suggest that many women develop UFs later in their reproductive years (Laughlin et al. 2010b) .
Little is known about UF pathophysiology or genetic risk factors beyond what has been learned from cell culture studies and tumor biology. The GWAS by Cha et al. (2011) and our findings support that common germline variation may contribute to increased UF risk. When meta-analyzed across all cohorts, including the prior GWAS, the level of statistical significance across all three previously associated GWAS SNPs exceeds the canonical genome-wide threshold for multiple testing. Taken together, these data support a consistent effect on risk and suggest that this locus may be functional or in tight LD with the functional SNP. Barriers often faced by UF researchers today include lack of imaging, limited racial diversity in cohorts, and availability of DNA samples. Our study population is unique, as all women included in this replication study had pelvic imaging available to confirm the presence or absence of a UF. Even though only a small number of genetic epidemiology studies have been performed, they have each yielded some important insights into the genetics of UF. Our findings suggest that there is common germline variation that increase risk for UFs among both EA and Japanese; however, further research is necessary in order to assess the role of BET1L and TNRC6B in other minority groups.
